Wave Life Sciences stock sets November 18 investor presentation

Published on 11/12/2026 at 14:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Wave Life Sciences stock has an upcoming investor presentation in London. CEO Paul Bolno will join an analyst-led fireside chat on November 18.

Wave prepares for investor conference

Chief Executive Paul Bolno is scheduled for an analyst-led fireside chat in London on November 18.
The company is advancing RNA medicine programs in obesity, alpha-1 antitrypsin deficiency and PNPLA3 liver disease.
Investors can access a live webcast through Wave Life Sciences' investor events page.

WVE, US94352A1043, Illustration mit AI erstellt.

Wave Life Sciences said on Wednesday, November 11, that Chief Executive Paul Bolno will participate in an analyst-led fireside chat at the Jefferies Global Healthcare Conference in London on Wednesday, November 18. The presentation is scheduled for 3:30 p.m. GMT, or 10:30 a.m. Eastern Time, according to the company announcement.

Wave Life Sciences stock traded at 3.14 euros on Lang & Schwarz at 2:08 p.m. CET on Thursday, November 12.

Pipeline remains central to outlook

Wave describes its business as focused on RNA medicines for rare and common disorders. Its lead programs include WVE-007 for obesity, WVE-006 for alpha-1 antitrypsin deficiency and WVE-008 for PNPLA3 I148M liver disease.

The company uses RNA interference and RNA editing approaches within its PRISM platform. The November conference appearance gives investors a scheduled opportunity to hear management discuss the platform and pipeline, although the announcement does not provide new clinical data or financial guidance.

Webcast offers next investor date

A live webcast will be available through the Investor Events section of Wave Life Sciences' website. A replay is expected to remain available there for a limited period after the presentation.

Wave Life Sciences stock at a glance

Company: Wave Life Sciences, Inc.
ISIN: US94352A1043
Ticker: WVE
Home exchange: Nasdaq
Lang & Schwarz quote: 3.14 euros at 2:08 p.m. CET on November 12, 2026

US healthcare shares remain sensitive to clinical milestones and regulatory updates. Current market reports are available in the market reports section.

More news and analyses on Wave Life Sciences stock.